Evidence map›Paper›PMID 39110307›Full record

ReviewMetabolomics : Official journal of the Metabolomic Society2024

Analysis types and quantification methods applied in UHPLC-MS metabolomics research: a tutorial.

Richard D Beger, Royston Goodacre, Christina M Jones, Katrice A Lippa, Oleg A Mayboroda, Donna O'Neill, Lukas Najdekr, Ioanna Ntai, Ian D Wilson, Warwick B Dunn

Abstract readReview
In one paragraph

Review in Metabolomics : Official journal of the Metabolomic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Metabolomics analyses and physical interventions in soccer: a systematic review.Metabolomics : Official journal of the Metabolomic Society · 2024
    Pooled it
  3. Trial
  4. Article
  5. International journal of molecular sciences · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Phenolic Compounds inPlants (Basel, Switzerland) · 2026
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Richard D BegerNational Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, 72079, USA.
Royston GoodacreDepartment of Biochemistry, Cell and Systems Biology, Centre for Metabolomics Research, Institute of Systems, Molecular, and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK.
Christina M JonesOffice of Advanced Manufacturing, National Institute of Standards and Technology, Gaithersburg, MD, 20899, USA.
Katrice A LippaOffice of Weights and Measures, National Institute of Standards and Technology, Gaithersburg, MD, 20899, USA.
Oleg A MayborodaCenter for Proteomics and Metabolomics, Leiden University Medical Centre, Leiden, The Netherlands.
Donna O'NeillSchool of Biosciences and Phenome Centre Birmingham, University of Birmingham, Birmingham, UK.
Lukas NajdekrFaculty of Medicine and Dentistry, Institute of Molecular and Translational Medicine, Palacký University Olomouc, 779 00, Olomouc, Czech Republic.
Ioanna NtaiBioMarin Pharmaceutical Inc., San Rafael, CA, USA.
Ian D WilsonDepartment of Biochemistry, Cell and Systems Biology, Centre for Metabolomics Research, Institute of Systems, Molecular, and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK.
Warwick B DunnDepartment of Biochemistry, Cell and Systems Biology, Centre for Metabolomics Research, Institute of Systems, Molecular, and Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK. warwick.dunn@liverpool.ac.uk.

Funding

Biotechnology and Biological Sciences Research Council BB/T007974/1Medical Research Council MR/S010483/1
6 · The paper itself

Abstract

backgroundDifferent types of analytical methods, with different characteristics, are applied in metabolomics and lipidomics research and include untargeted, targeted and semi-targeted methods. Ultra High Performance Liquid Chromatography-Mass Spectrometry is one of the most frequently applied measurement instruments in metabolomics because of its ability to detect a large number of water-soluble and lipid metabolites over a wide range of concentrations in short analysis times. Methods applied for the detection and quantification of metabolites differ and can either report a (normalised) peak area or an absolute concentration. AIM OF REVIEW: In this tutorial we aim to (1) define similarities and differences between different analytical approaches applied in metabolomics and (2) define how amounts or absolute concentrations of endogenous metabolites can be determined together with the advantages and limitations of each approach in relation to the accuracy and precision when concentrations are reported. KEY SCIENTIFIC CONCEPTS OF REVIEW: The pre-analysis knowledge of metabolites to be targeted, the requirement for (normalised) peak responses or absolute concentrations to be reported and the number of metabolites to be reported define whether an untargeted, targeted or semi-targeted method is applied. Fully untargeted methods can only provide (normalised) peak responses and fold changes which can be reported even when the structural identity of the metabolite is not known. Targeted methods, where the analytes are known prior to the analysis, can also report fold changes. Semi-targeted methods apply a mix of characteristics of both untargeted and targeted assays. For the reporting of absolute concentrations of metabolites, the analytes are not only predefined but optimized analytical methods should be developed and validated for each analyte so that the accuracy and precision of concentration data collected for biological samples can be reported as fit for purpose and be reviewed by the scientific community.

Indexed as

Mass SpectrometryMetabolomicsChromatography, High Pressure LiquidHumansMetabolomicsQuantificationSemi-targetedTargetedUHPLC-MSUntargetedValidation

Identifiers

PMID39110307
PMCPMC11306277

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.